Atopy, which is characterized by increased levels of immunoglobulin E (IgE) against common environmental allergens, is considered the strongest predisposing factor for asthma and atopic dermatitis (AD). Mutations in the gene encoding serine protease inhibitor Kazal-type 5 (SPINK5) are responsible for Netherton syndrome, a rare skin disorder characterized by greatly elevated IgE levels with atopic manifestations. A recent study of Caucasian AD families showed that maternally derived alleles of the SPINK5 gene are associated with development of AD and asthma, suggesting the parent-of-origin effect for the development of atopic diseases in the SPINK5 gene. We studied the possible association of the SPINK5 gene for the development of atopic diseases by determining the genotypes of five polymorphisms in a Japanese population. Ttransmission disequilibrium tests revealed an association of SPINK5 polymorphisms with AD but not with asthma. Our data indicate that the SPINK5 gene is associated with AD across ethnicities.
Atopic diseases such as asthma and atopic dermatitis (AD) are major causes of morbidity in developed countries and have increased in frequency.
1,2 Atopy, which is characterized by increased levels of immunoglobulin E (IgE) against common environmental allergens, is considered the strongest predisposing factor for asthma. More than 90% of children with asthma develop IgE specific for house dust mites, and dust mite allergy is associated strongly with asthma. 3, 4 AD is characterized by an intensely pruritic rash with a characteristic morphology and distribution pattern. It affects 10-20% of children in developed countries and shows strong familial aggregation. 5 Eighty percent of patients with AD cases show elevated total serum IgE levels, 6 and atopic mechanisms dominate our current understanding of the pathogenesis of AD. 7 Serine protease inhibitor Kazal-type 5 (SPINK5) is responsible for Netherton syndrome, 8 a rare recessive skin disorder that is accompanied by atopy. 9 The SPINK5 gene comprises 33 exons and spans approximately 61 kb on human chromosome 5q32. SPINK5 is involved in regulation of proteolysis in epithelia formation and keratinocyte terminal differentiation, and some mutations in the SPINK5 gene cause defects in the skin barrier.
8 SPINK5 is expressed in thymus, tonsil and oral mucosa, 10 and it is suggested that abnormal maturation of T lymphocytes in patients with Netherton syndrome alters Th2-type responsiveness to allergens, leading to elevated IgE levels. 8 A recent study of Caucasian AD families showed that maternally derived alleles of the SPINK5 gene are associated with development of atopic diseases such as AD and asthma, suggesting a parent-oforigin effect in the development of atopic diseases.
11
To confirm an involvement of the SPINK5 gene in atopic diseases, these findings must be replicated in an independent set of families. In the present study, we analyzed five missense polymorphisms in the SPINK5 gene in Japanese atopic families identified through asthmatic children or subjects with AD. The study was approved by the Committee of Ethics of the University of Tsukuba.
Among six missense mutations reported by Walley and colleagues, 11 we selected five (Asp106Asn, Asn368-Ser, Asp386Asn, Glu420Lys and Glu825Asp) for genotyping. We did not examine the His9724Arg mutation because it was not found in 100 subjects genotyped. Frequencies of the SPINK5 genotypes in parents did not deviate from frequencies predicted by Hardy-Weinberg equilibrium examined by w 2 test (P40.1). Allele frequencies of SPINK5 in the parents are 0.19 for Asn106, 0.59 for Ser368, 0.47 for Asn386, 0.58 for Lys420 and 0.25 for Asp825, and these frequencies differed significantly from those reported for British families with AD 11 (the frequencies in the British families were 0.03, 0.50, 0.13, 0.48 and 0.08, respectively; Po0.001 for all polymorphisms). Significant linkage disequilibrium was observed among five polymorphisms in the SPINK5 genes that we tested (Table 1) .
Transmission disequilibrium tests (TDTs) revealed that the Ser368 and Lys420 alleles were transmitted preferentially to offspring with AD (Table 2) . However, this trend was not observed in asthmatic children (Table 2) .
In the present Japanese sample, SPINK5 was associated with development of AD but not asthma. Walley and colleagues found significant associations between maternally derived Lys420 allele of SPINK5 and atopy, AD, asthma and total serum IgE levels. 11 In the present study, the Ser368 and Lys420 alleles were transmitted preferentially to offspring with AD. Maternally derived Ser368 and Lys420 alleles are transmitted preferentially to offspring with AD, whereas paternally derived alleles are transmitted to affected offspring at nearly equal frequencies. The Ser368 and Lys420 alleles are in significant linkage disequilibrium, therefore, it is difficult to determine which is actually involved in development of AD. Our raw transmission data for maternally and paternally derived alleles in AD families suggest that there is a possible parent-of-origin effect in AD. However, our sample size for AD was not large enough to perform a parent-of-origin likelihood ratio test as was done in the previous study. 11 We did not find any association between asthma and SPINK5 polymorphisms. The detection power for the Asn368Ser or Glu420Lys polymorphisms is 0.98 at the alpha level of 0.05 with our sample size if the relative risk for asthma in those persons carrying a putative risk allele is 2.0 compared with that in persons without the allele. Therefore, our failure to detect an association was not due to the sample size, although minor contributions by these alleles in the development of asthma cannot be excluded.
The present findings provide support for a role of the SPINK5 gene in the etiology of AD. Alhough it is not known whether SPINK5 polymorphisms are primarily involved in AD or general atopic status, our data indicate that the SPINK5 gene is involved in development of AD across ethnicities. Note: Probands in the asthmatic and AD families were outpatients who visited the Pediatric Allergy Clinic or the Department of Dermatology of the University Hospital of Tsukuba (Japan). A full verbal and written explanation of the study was given to all family members interviewed, and 144 asthmatic families (476 individuals) and 41 AD families (177 members) gave informed consent and participated in the study. Criteria for diagnosis of asthma were described previously. 12 AD was diagnosed in subjects according to the criteria of Hanifin and Rajka. 13 Typing of the Glu420Lys and Glu825Asp polymorphisms was performed as described previously. 11 For genotyping of Asp106Asn, Asn368Ser and Asp386Asn polymorphisms, the region of interest was amplified with primers 5 0 TATTAGCTCAATGTAGCCTTC-3 0 and 5 0 AGGAC-AGATAAAATCCCCGT-3 0 for Asp106Asn and primers 5 0 GAGATGTAACATTAGTTTCTGC-3 0 and 5 0 ATGTCTCCAATCAGACAGTTTCTC-3 0 for Asn368Ser and Asp386Asn. The expected PCR product sizes were 367 and 197 bp, respectively. The Asp106>Asn, Asn368>Ser and Asp386>Asn mutations were identified by the loss of a BsmAI site, gain of a BtsI site and loss of an MboI site, respectively. TDT was performed with SIB-PAIR program. 14 A proband was selected from each family for TDT analysis, and 144 trios for asthma and 41 trios for AD were analyzed for TDT. A P-value of o0.05 was considered statistically significant.
